Global Pulmonary Drugs Market Study 2016-2026, by Segment (Inhaled Corticosteroids (ICS), Long-Acting Beta2-Agonists (LABA), … …), by Market (Asthma & COPD, Allergic Rhinitis, … …), by Company (AstraZeneca plc, Bayer AG, … …)

SKU ID :99ST-14631990 | Published Date: 29-Oct-2019 | No. of pages: 59
Table of Content 1 Industry Overview 1.1 Pulmonary Drugs Industry 1.1.1 Overview 1.1.2 Products of Major Companies 1.2 Market Segment 1.2.1 Industry Chain 1.2.2 Consumer Distribution 1.3 Price & Cost Overview 2 Pulmonary Drugs Market by Type 2.1 By Type 2.1.1 Inhaled Corticosteroids (ICS) 2.1.2 Long-Acting Beta2-Agonists (LABA) 2.1.3 Antihistamine 2.1.4 Vasodilators 2.1.5 Short-Acting Beta2-Agonists (SABA) 2.1.6 Anticholinergics 2.1.7 Combination Drugs 2.1.8 MAbs 2.1.9 Enzymes 2.1.10 Antibiotics & Antileukotrienes 2.2 Market Size by Type 2.3 Market Forecast by Type 3 Global Market Demand 3.1 Segment Overview 3.1.1 Asthma & COPD 3.1.2 Allergic Rhinitis 3.1.3 Pulmonary Arterial Hypertension 3.1.4 Cystic Fibrosis 3.2 Market Size by Demand 3.3 Market Forecast by Demand 4 Major Region Market 4.1 Global Market Overview 4.1.1 Market Size & Growth 4.1.2 Market Forecast 4.2 Major Region 4.2.1 Market Size & Growth 4.2.2 Market Forecast 5 Major Companies List 5.1 AstraZeneca plc (Company Profile, Sales Data etc.) 5.2 Bayer AG (Company Profile, Sales Data etc.) 5.3 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.) 5.4 Actelion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.) 5.5 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.) 5.6 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.) 5.7 Merck & Co., Inc. (Company Profile, Sales Data etc.) 5.8 Novartis AG (Company Profile, Sales Data etc.) 5.9 GlaxoSmithKline plc (Company Profile, Sales Data etc.) 5.10 Sunovion Pharmaceuticals (Company Profile, Sales Data etc.) 6 Conclusion
List of Table Table Global Pulmonary Drugs Market 2016-2019, by Type, in USD Million Table Global Pulmonary Drugs Market 2016-2019, by Type, in Volume Table Global Pulmonary Drugs Market Forecast 2020-2026, by Type, in USD Million Table Global Pulmonary Drugs Market Forecast 2020-2026, by Type, in Volume Table Global Pulmonary Drugs Demand 2016-2019, in USD Million Table Global Pulmonary Drugs Demand 2016-2019, in Volume Table Global Pulmonary Drugs Demand Forecast 2020-2026, in USD Million Table Global Pulmonary Drugs Demand Forecast 2020-2026, in Volume Table Global Pulmonary Drugs Market Size & Growth 2016-2019, in USD Million Table Global Pulmonary Drugs Market Size & Growth 2016-2019, in Volume Table Global Pulmonary Drugs Market Forecast 2020-2026, in USD Million Table Global Pulmonary Drugs Market Forecast 2020-2026, in Volume Table Global Pulmonary Drugs Market 2016-2019, by Region, in USD Million Table Global Pulmonary Drugs Market 2016-2019, by Region, in Volume Table Global Pulmonary Drugs Market Forecast 2020-2026, by Region, in USD Million Table Global Pulmonary Drugs Market Forecast 2020-2026, by Region, in Volume Table AstraZeneca plc Overview List Table Pulmonary Drugs Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table AstraZeneca plc Overview List Table Pulmonary Drugs Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bayer AG Overview List Table Pulmonary Drugs Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Teva Pharmaceutical Industries Ltd Overview List Table Pulmonary Drugs Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Actelion Pharmaceuticals, Inc. Overview List Table Pulmonary Drugs Business Operation of Actelion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Boehringer Ingelheim GmbH Overview List Table Pulmonary Drugs Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table F. Hoffmann-La Roche Ltd. Overview List Table Pulmonary Drugs Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Merck & Co., Inc. Overview List Table Pulmonary Drugs Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novartis AG Overview List Table Pulmonary Drugs Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table GlaxoSmithKline plc Overview List Table Pulmonary Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sunovion Pharmaceuticals Overview List Table Pulmonary Drugs Business Operation of Sunovion Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) List of Figure Figure Global Pulmonary Drugs Market Growth 2016-2019, by Type, in USD Million Figure Global Pulmonary Drugs Market Growth 2016-2019, by Type, in Volume
  • PRICE
  • $1800
    $3600

Our Clients